BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 36115522)

  • 1. High-intensity statin therapy reduces risk of amputation and reintervention among patients undergoing lower extremity bypass for chronic limb-threatening ischemia.
    He JJ; Horns JJ; Kraiss LW; Smith BK; Griffin CL; DeMartino RR; Sarfati MR; Brooke BS
    J Vasc Surg; 2023 Feb; 77(2):497-505. PubMed ID: 36115522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic disparities in 3-year outcomes following infrainguinal bypass for chronic limb-threatening ischemia.
    Anjorin AC; Marcaccio CL; Patel PB; Wang SX; Rowe V; Aulivola B; Wyers MC; Schermerhorn ML
    J Vasc Surg; 2022 Nov; 76(5):1335-1346.e7. PubMed ID: 35768062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative.
    Cleman J; Romain G; Grubman S; Guzman RJ; Smolderen KG; Mena-Hurtado C
    J Vasc Surg; 2023 Sep; 78(3):745-753.e6. PubMed ID: 37207790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia.
    O'Donnell TFX; Deery SE; Darling JD; Shean KE; Mittleman MA; Yee GN; Dernbach MR; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):572-578. PubMed ID: 28506476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Statins on Survival and Limb Salvage in Patients Undergoing Peripheral Endovascular Intervention for Chronic Limb-Threatening Ischemia.
    Chang M; O'Brien-Irr M; Montross B; Dosluoglu H; Harris L; Dryjski M; Rivero M; Khan SZ
    Ann Vasc Surg; 2023 Apr; 91():20-27. PubMed ID: 36503021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immunosuppression does not affect revascularization outcomes in patients with chronic limb-threatening ischemia.
    Romary DJ; Darling JD; Patel PB; Dash SP; Schermerhorn ML; Lee AM
    J Vasc Surg; 2024 Jan; 79(1):111-119.e2. PubMed ID: 37717639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of comorbid depression with mortality and amputation risk in patients with chronic limb-threatening ischemia.
    Zielke T; Korepta L; Wesolowski M; D'Andrea M; Aulivola B
    J Vasc Surg; 2024 Jan; 79(1):96-101.e1. PubMed ID: 37704093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH; El Khoury R; Wu B; Gasper WJ; Schneider PA; Hiramoto JS; Vartanian SM; Conte MS
    J Vasc Surg; 2023 Apr; 77(4):1137-1146.e3. PubMed ID: 36584906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Reintervention After Infrainguinal Revascularization for Chronic Limb-Threatening Ischemia in Women.
    Wu B; Lancaster EM; Ramirez JL; Zarkowsky DS; Reyzelman AM; Gasper WJ; Conte MS; Hiramoto JS
    Ann Vasc Surg; 2020 Nov; 69():307-316. PubMed ID: 32561241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
    Chen SL; Whealon MD; Kabutey NK; Kuo IJ; Sgroi MD; Fujitani RM
    J Vasc Surg; 2017 Jun; 65(6):1680-1689. PubMed ID: 28527930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial.
    Conte MS; Azene E; Doros G; Gasper WJ; Hamza T; Kashyap VS; Guzman R; Mena-Hurtado C; Menard MT; Rosenfield K; Rowe VL; Strong M; Farber A
    J Vasc Surg; 2024 Jun; 79(6):1428-1437.e4. PubMed ID: 38368997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.
    El Khoury R; Wu B; Kupiec-Weglinski SA; Liu IH; Edwards CT; Lancaster EM; Hiramoto JS; Vartanian SM; Schneider PA; Conte MS
    J Vasc Surg; 2022 Oct; 76(4):997-1005.e2. PubMed ID: 35697305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of major amputation despite patent bypass grafts.
    Smith AD; Hawkins AT; Schaumeier MJ; de Vos MS; Conte MS; Nguyen LL
    J Vasc Surg; 2016 May; 63(5):1279-88. PubMed ID: 26860641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of postoperative antithrombotic therapy on lower extremity outcomes after infrapopliteal bypass for chronic limb-threatening ischemia.
    Marcaccio CL; Patel PB; Wang S; Rastogi V; Moreira CC; Siracuse JJ; Schermerhorn ML; Stangenberg L
    J Vasc Surg; 2022 May; 75(5):1696-1706.e4. PubMed ID: 35074410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Outcomes of Patients Undergoing Infrainguinal Bypass in the Endovascular Era.
    Bloch RA; McIntosh EE; Pomposelli FB; Prushik SG; Shean KE; Conrad MF
    Ann Vasc Surg; 2023 Nov; 97():59-65. PubMed ID: 37169246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.
    Darling JD; McCallum JC; Soden PA; Guzman RJ; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
    J Vasc Surg; 2017 Mar; 65(3):695-704. PubMed ID: 28073665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and other factors associated with mortality after major lower extremity amputation.
    DeCarlo C; Scher L; Shariff S; Phair J; Lipsitz E; Garg K
    J Vasc Surg; 2017 Jul; 66(1):216-225. PubMed ID: 28431865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival.
    Suckow BD; Kraiss LW; Schanzer A; Stone DH; Kalish J; DeMartino RR; Cronenwett JL; Goodney PP;
    J Vasc Surg; 2015 Jan; 61(1):126-33. PubMed ID: 25037607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia.
    Hicks CW; Najafian A; Farber A; Menard MT; Malas MB; Black JH; Abularrage CJ
    J Vasc Surg; 2016 Dec; 64(6):1667-1674.e1. PubMed ID: 27871493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.